<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04580758</url>
  </required_header>
  <id_info>
    <org_study_id>Kasr El Aini Hospital</org_study_id>
    <nct_id>NCT04580758</nct_id>
  </id_info>
  <brief_title>Fractional CO2 Laser Combined With PRP Fluid Versus Gel in Treatment of Acne Scars</brief_title>
  <acronym>PRP</acronym>
  <official_title>Fractional CO2 Laser Combined With Platelet Rich Plasma Fluid Versus Gel Form in Treatment of Atrophic Acne Scars: A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yasmine Ahmed Abd El-Maguid El-Hadidy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kasr El Aini Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to test the efficacy of fractional laser combined with either PRP fluid or PRP&#xD;
      gel in the treatment of atrophic acne scars&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will include 20 patients, treated with fractional CO2 laser plus PRP fluid on one&#xD;
      side of the face and fractional CO2 laser plus PRP gel on the other side.&#xD;
&#xD;
      Choosing which side of the face will be injected with PRP fluid and which side will be&#xD;
      injected with PRP gel will be chosen according to a randomization table for each patient.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 25, 2020</start_date>
  <completion_date type="Anticipated">January 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Test which combination is more effective, fractional laser with PRP fluid or fractional laser with PRP gel</measure>
    <time_frame>one year</time_frame>
    <description>Effectiveness of each combination will be measured with OCT, depth of a fixed scar on each side of the face will be measured at baseline and then compared with 1 month after the last session and 3 months after the last session</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Atrophic Acne Scar</condition>
  <arm_group>
    <arm_group_label>Fractional laser with PRP fluid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fractional CO2 laser then the PRP is injected afterwards</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fractional laser with PRP gel</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fractional CO2 laser then the PRP gel is injected afterwards</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Fractional laser with PRP fluid or PRP gel</intervention_name>
    <description>20 participants divided into 2 groups of 10 10 participants will do Fractional laser with PRP fluid sessions and 10 participants will do Fractional laser with PRP gel</description>
    <arm_group_label>Fractional laser with PRP fluid</arm_group_label>
    <arm_group_label>Fractional laser with PRP gel</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age above 18&#xD;
&#xD;
          -  Both genders&#xD;
&#xD;
          -  Skin types III - V&#xD;
&#xD;
          -  Willingness and ability to comply with the requirements of the protocol&#xD;
&#xD;
          -  Atrophic acne scars&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with active acne&#xD;
&#xD;
          -  Patients with herpes labialis, bacterial infections, other infections such as HBV. HCV&#xD;
             or HIV.&#xD;
&#xD;
          -  Oral isotretinoin use in the previous 6 months&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Tendency to keloid formation&#xD;
&#xD;
          -  Patients with severe systemic illness or malignancy&#xD;
&#xD;
          -  Patients with connective tissue diseases&#xD;
&#xD;
          -  Patients with bleeding tendencies or any other hematological disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Heba A Abd El Kader, MD</last_name>
    <phone>01142479792</phone>
    <email>H_abdelkader2007@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Heba I Gawdat</last_name>
    <phone>01142479792</phone>
    <email>H_abdelkader2007@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kasr Al Ainy Hospital</name>
      <address>
        <city>Giza</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yasmin A El Hadidy, MB BCh</last_name>
      <phone>01142479792</phone>
      <email>yasmin_ahmed_92@yashoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Heba A Abd El Kader, MD</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 28, 2020</study_first_submitted>
  <study_first_submitted_qc>October 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 8, 2020</study_first_posted>
  <last_update_submitted>October 7, 2020</last_update_submitted>
  <last_update_submitted_qc>October 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Kasr El Aini Hospital</investigator_affiliation>
    <investigator_full_name>Yasmine Ahmed Abd El-Maguid El-Hadidy</investigator_full_name>
    <investigator_title>Dermatology Resident</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrophy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

